US FDA Approves Asahi Kasei's Drug for Persistent Herpes Infections

3-line summary

• The US FDA approved Asahi Kasei's drug for persistent herpes infections, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.